INS and cancer: Insulin is a humeral growth factor for a variety of cancer cells in vitro, and a variety of therapies targeting the insulin-like growth factor receptor are undergoing evaluation as potential anti-cancer treatment (Maki, 2010; Golan and Javle, 2011).